Valuation: SciBase Holding AB

Market Cap 360M 37.34M 32.63M 30.11M 27.76M 52.32M 3.6B 53.48M 142M 1.76B 140M 137M 6.06B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 360M 37.34M 32.63M 30.11M 27.76M 52.32M 3.6B 53.48M 142M 1.76B 140M 137M 6.06B EV / Sales 2026 *
5.46x
EV / Sales 2027 * 3.45x
Free-Float
77.17%
Yield 2026 *
-
Yield 2027 * -
1 day+0.57%
1 week+7.81%
Current month+8.31%
1 month-28.02%
3 months-14.56%
6 months+56.44%
Current year+2.03%
1 week 32
Extreme 32
35.5
1 month 29.65
Extreme 29.65
42.35
Current year 18.5
Extreme 18.5
54
1 year 18.5
Extreme 18.5
54
3 years 18.5
Extreme 18.5
148.4
5 years 18.5
Extreme 18.5
657
10 years 18.5
Extreme 18.5
3,020
Manager TitleAgeSince
Chief Executive Officer 59 2023-09-30
Director of Finance/CFO 64 2013-12-31
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 68 -
Chairman 66 2024-06-12
Director/Board Member 60 2017-05-15
Change 5-day change 1-year change 3-year change Capi.($)
+0.57%+7.81%-7.12%-69.39% 37.34M
-1.46%+0.58%+15.63%-20.90% 17.53B
-6.27%-3.41%+0.47%+82.98% 1.67B
-3.04%-4.32%-34.48%-78.97% 1.24B
-1.34%-5.93%-37.77%+12.26% 1.01B
-4.06%+5.84%-27.53%-52.68% 672M
-7.46%-0.30%-40.81%-57.56% 576M
-1.49%-4.16%+34.90%-53.69% 453M
-1.26%+0.64%-54.16%-58.79% 387M
-3.29%+16.11%+47.89% - 332M
Average -2.88%+1.89%-10.30%-32.97% 2.39B
Weighted average by Cap. -2.03%+4.10%+6.78%-18.30%

Financials

2026 *2027 *
Net sales 65.9M 6.84M 5.97M 5.51M 5.08M 9.58M 658M 9.79M 25.92M 322M 25.68M 25.11M 1.11B 104M 10.81M 9.45M 8.72M 8.04M 15.15M 1.04B 15.48M 40.98M 510M 40.6M 39.71M 1.76B
Net income -66.3M -6.88M -6.01M -5.55M -5.11M -9.64M -662M -9.85M -26.08M -324M -25.83M -25.27M -1.12B -51.5M -5.34M -4.67M -4.31M -3.97M -7.49M -515M -7.65M -20.26M -252M -20.07M -19.63M -868M
Net Debt - -
Logo SciBase Holding AB
SciBase Holding AB (publ) is a Sweden-based company engaged in the medical equipment industry. The Company specializes in the manufacture of point of care device, called Nevisense, which is aimed to detect of malignant melanoma. Nevisense analyze suspicious lesions by using Electrical Impedance Spectroscopy (EIS) which is applied as an electrical signal to the skin. SciBase Holding AB (publ) specializes in early detection and prevention in dermatology. The Company develops and commercializes Nevisense, a point-of-care platform that combines AI (artificial intelligence) and advanced EIS technology to elevate diagnostic accuracy, ensuring proactive skin health management. SciBase Holding AB (publ) combines advanced EIS technology with AI to empower healthcare professionals by improving diagnostic precision, facilitating disease monitoring, and enabling early detection of skin cancer.
Employees
49
Date Price Change Volume
26-07-16 SEK 35.20 +0.57% 667
26-07-15 SEK 35.00 0.00% 907
26-07-14 SEK 35.00 +0.72% 3,471
26-07-13 SEK 34.75 +6.60% 5,661
26-07-10 SEK 32.60 -0.15% 934

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. SCIB Stock